个性化支臂疗法:应用和未来方向
Piyush Pathak1, Justin J Thomas1, Arjit Baghwala2
1Department of Radiation Oncology, Baylor College of Medicine, Houston, TX 77030, USA.
Cancers
|October 16, 2024
概括
个性化支臂疗法是一种精确的辐射技术,正随着人工智能和免疫疗法等新技术的发展而发展. 这种方法提供了量身定制的癌症治疗方法,对于未来的瘤学个性化医学至关重要.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
背景情况:
- 支臂疗法为瘤疾病提供符合性和适应性辐射疗法.
- 个性化医疗正在彻底改变癌症治疗方法.
研究的目的:
- 审查个性化支臂治疗的理由,应用,技术进步和未来方向.
- 突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
主要方法:
- 审查当前关于支臂治疗进展的文献.
- 探索综合技术 (成像,人工智能,3D打印).
- 对新兴研究的分析 (基因组学,免疫疗法,新型应用器).
主要成果:
- 先进的成像,3D打印的应用器和人工智能提高了手臂治疗的效率.
- 基因组测试和生物标志物使得精细的患者和剂量选择.
- 与免疫疗法结合显示出协同作用的潜力;新型应用器优化剂量分配.
结论:
- 个性化支臂疗法是未来癌症护理的关键组成部分,因为它具有针对性,个性化的治疗能力.
- 挑战包括培训需求和扩大治疗范围到更多的恶性瘤.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


